Stocks and Investing Stocks and Investing
Mon, October 29, 2018
Fri, October 26, 2018

Kevin Ellich Downgraded (AMED) to Hold and Decreased Target to $104 on, Oct 26th, 2018


Published on 2024-10-26 10:01:12 - WOPRAI, Kevin Ellich
  Print publication without navigation


Kevin Ellich of Craig-Hallum, Downgraded "Amedisys, Inc." (AMED) to Hold and Decreased Target from $116 to $104 on, Oct 26th, 2018.

Kevin has made no other calls on AMED in the last 4 months.



There are 3 other peers that have a rating on AMED. Out of the 3 peers that are also analyzing AMED, 2 agree with Kevin's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Joseph France of "Cantor Fitzgerald" Maintained at Hold with Increased Target to $125 on, Thursday, October 11th, 2018
  • Whit Mayo of "Baird" Maintained at Hold with Increased Target to $120 on, Thursday, October 11th, 2018


This is the rating of the analyst that currently disagrees with Kevin


  • Joanna Gajuk of "B of A Securities" Maintained at Strong Buy with Increased Target to $139 on, Tuesday, September 18th, 2018

Contributing Sources